Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in target identification against hepatitis C virus.

Volker Brass1, Hubert E Blum, Darius Moradpour

  • 1Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany. Darius.Moradpour@uni-freiburg.de

Expert Opinion on Therapeutic Targets
|July 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis.

Thrombosis research·2026
Same author

Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

[GLP-1 agonists : indications and pancreatic and endoscopic safety considerations].

Revue medicale suisse·2026
Same author

[Hepatitis A-E: the essentials].

Revue medicale suisse·2025
Same author

Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9).

The Lancet. Haematology·2025
Same author

Effect of direct oral anticoagulants in cirrhosis: an in vitro study.

Journal of thrombosis and haemostasis : JTH·2025

New hepatitis C virus (HCV) therapies targeting viral serine protease show promise. These advancements in antiviral strategies offer potential new treatments for chronic hepatitis C, a major cause of liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Drug Discovery

Background:

  • Chronic hepatitis C is a significant global health issue, leading to liver cirrhosis and hepatocellular carcinoma.
  • Understanding hepatitis C virus (HCV) molecular virology has identified new targets for antiviral therapies.

Purpose of the Study:

  • To evaluate novel therapeutic strategies for chronic hepatitis C.
  • To report on the efficacy of a specific HCV serine protease inhibitor.

Main Methods:

  • Development of in vitro and in vivo model systems for evaluating therapeutic strategies.
  • Conducting proof-of-concept clinical studies for novel antiviral agents.

Main Results:

  • Positive results reported from proof-of-concept clinical studies.

Related Experiment Videos

  • A specific hepatitis C virus serine protease inhibitor demonstrated efficacy.

    • Conclusions:

    • Novel antiviral strategies, including serine protease inhibitors, show potential for treating chronic hepatitis C.
    • These new approaches may enhance current treatment options for hepatitis C virus infection.